MET or SHP2 inhibition enhances targeted therapies and delays the emergence of resistance in oncogene-driven NSCLCNadine Reischmann, Lorenz Pudelko,Christopher Stroh,Nina Linde,Doreen Musch,Marina Keil,Linda Pudelko,Christina Esdar,Andree Blaukat,Karl M. Schumacher,Niki KarachaliouCANCER RESEARCH(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要